首页> 美国卫生研究院文献>BMC Musculoskeletal Disorders >TRAIL Death Receptor-4 Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis
【2h】

TRAIL Death Receptor-4 Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis

机译:类风湿关节炎患者CD8 + T细胞上TRAIL死亡受体4诱饵受体1和诱饵受体2的表达与疾病的严重程度相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disorder. Although the pathogenesis of disease is unclear, it is well known that T cells play a major role in both development and perpetuation of RA through activating macrophages and B cells. Since the lack of TNF-Related Apoptosis Inducing Ligand (TRAIL) expression resulted in defective thymocyte apoptosis leading to an autoimmune disease, we explored evidence for alterations in TRAIL/TRAIL receptor expression on peripheral T lymphocytes in the molecular mechanism of RA development.
机译:背景类风湿关节炎(RA)是一种慢性自身免疫性炎性疾病。尽管尚不清楚疾病的发病机理,但众所周知,T细胞通过激活巨噬细胞和B细胞在RA的发展和永存中起着重要作用。由于缺乏TNF相关的凋亡诱导配体(TRAIL)表达导致胸腺细胞凋亡缺陷导致自身免疫性疾病,因此我们探索了在RA发育的分子机制中外周T淋巴细胞TRAIL / TRAIL受体表达发生改变的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号